KSE 100 3,647.8

107,174.6 (3.5%)

KMI 30 6,907.0

158,209.1 (4.6%)

CPHL

Pharmaceuticals

Citi Pharma Limited

Current Price

64.66

Change

-2.44

% Change

-3.64%

Day High

65.65

/

Day Low

60.50

Volume

5.80mn

Standardized
As Reported

Income Statement

In Million

	1Q2024	2Q2024	3Q2024	1Q2025	2Q2025	Trend
Turnover - net	2,701.22	3,275.16	3,558.87	3,224.64	3,534.43
Cost of sales	-2,454.77	-2,650.00	-3,087.35	-2,796.14	-2,995.30
Gross profit	246.46	625.16	471.53	428.51	539.13
Administrative expenses	-48.27	-51.26	-55.25	-46.40	-58.25
Selling expenses	-38.64	-31.51	-30.36	-40.70	-43.14
Opertaing profit	159.57	542.40	385.92	341.42	437.75
Financial charges	-86.81	-70.17	-43.83	-64.58	-67.87
Other income	106.20	157.40	49.34	92.22	50.42
Other expenses	-12.35	-43.15	-26.57	-28.78	-26.14
Profit before tax	166.62	586.49	364.87	340.29	394.17
Taxation	-72.18	-210.90	-153.53	-138.81	-137.20
Profit after tax	94.45	375.60	211.34	201.49	256.97

Balance Sheet

In Million

	1Q2024	2Q2024	3Q2024	1Q2025	2Q2025	Trend
Share Capital	2,284.61	2,284.61	2,284.61	2,284.61	2,284.61
Shareholder Equity	5,467.52	5,271.97	5,483.31	5,834.62	5,349.10
Non Current Liabilities	166.59	178.51	168.81	210.10	237.33
Current Liabilities	4,344.92	4,197.79	4,902.62	6,150.65	6,980.59
Total Liabilities	4,511.51	4,376.30	5,071.43	6,360.75	7,217.92
Total Liabilities & Equity	9,979.04	9,648.28	10,554.75	12,195.38	12,567.02
Non Current Assets	3,402.88	3,638.07	3,864.61	3,813.44	3,918.86
Current Assets	6,576.15	6,010.20	6,690.13	8,381.93	8,648.16
Total Assets	9,979.04	9,648.28	10,554.75	12,195.38	12,567.02

Cash Flow

In Million

	1Q2024	2Q2024	3Q2024	1Q2025	2Q2025	Trend
Cash Flow From Operating Activities	45.71	1,156.92	1,648.72	-54.42	338.83
Cash Flow From Investing Activities	9.50	-233.89	-503.77	-27.52	-49.41
Cash Flow From Financing Activities	-74.31	-1,078.00	-1,092.13	5.36	-397.81
Net increase/(decrease) in cash and cash equivalents	-19.09	-154.96	52.82	-76.58	-108.38
Cash and cash equivalents at the beginning of the year	1,411.53	1,411.53	1,411.53	1,278.33	1,278.33
Cash and cash equivalents at the end of the year	1,392.44	1,256.57	1,464.36	1,201.75	1,169.96

Income Statement

In Million

	Q1 - 2023	Q2 - 2023	Q3 - 2023	Q4 - 2023	Q1 - 2024	Q2 - 2024	Q3 - 2024	Q4 - 2024	Q1 - 2025	Q2 - 2025	Trend
Net Sales	3,118.07	3,052.79	2,688.72	3,537.38	2,701.22	3,275.16	3,558.87	2,873.97	3,224.64	3,534.43
Cost of Good Sold	2,747.68	2,507.75	2,338.31	3,296.11	2,454.76	2,649.99	3,087.34	2,630.93	2,796.13	2,995.29
Gross Profit / Loss	370.39	545.03	350.41	241.26	246.46	625.16	471.52	243.03	428.51	539.13
Other Operating Expenses	91.59	122.84	72.53	168.86	99.24	125.90	112.17	157.43	115.86	127.51
Other Income	47.59	4.93	17.32	222.35	106.20	157.40	49.34	176.71	92.22	50.42
Operating Profit / Loss	283.01	460.34	288.35	135.76	159.57	542.40	385.92	117.73	341.42	437.75
Financial Charges	157.05	35.45	156.02	37.70	86.80	70.16	43.82	99.10	64.57	67.86
Profit Before Taxation	169.33	462.58	139.18	186.15	166.62	586.49	364.87	163.20	340.29	394.17
Taxation	-23.53	-167.76	-46.42	-61.58	-72.18	-210.90	-153.53	-11.14	-138.81	-137.20
Profit / Loss After Taxation	145.80	294.82	92.76	124.58	94.45	375.60	211.34	152.06	201.49	256.97
Basic Earning Per Share	0.64	1.29	0.41	0.54	0.41	1.64	0.93	0.67	0.88	1.12
Diluted Earning Per Share	0.64	1.29	0.41	0.54	0.41	1.64	0.93	0.67	0.88	1.12

Balance Sheet

In Million

	Q1 - 2023	Q2 - 2023	Q3 - 2023	Q4 - 2023	Q1 - 2024	Q2 - 2024	Q3 - 2024	Q4 - 2024	Q1 - 2025	Q2 - 2025	Trend
Share Capital	2,284.61	2,284.61	2,284.61	2,284.61	2,284.61	2,284.61	2,284.61	2,284.61	2,284.61	2,284.61
Shareholder Equity	4,831.67	5,126.50	5,219.27	5,373.07	5,467.52	5,271.97	5,483.31	5,633.12	5,834.62	5,349.10
Non Current Liabilities	147.13	125.61	134.38	158.07	166.59	178.50	168.81	206.71	210.10	237.33
Current Liabilities	3,418.19	3,587.94	4,639.48	4,453.01	4,344.92	4,197.79	4,902.62	5,562.58	6,150.65	6,980.59
Total Liabilities	3,565.32	3,713.55	4,773.87	4,611.09	4,511.51	4,376.30	5,071.43	5,769.29	6,360.75	7,217.92
Total Capital & Liabilities	8,397.00	8,840.06	9,993.15	9,984.16	9,979.04	9,648.27	10,554.75	11,402.42	12,195.37	12,567.02
Non Current Assets	2,793.04	2,837.06	3,388.61	3,400.46	3,402.88	3,638.07	3,864.61	3,827.00	3,813.44	3,918.85
Current Assets	5,603.96	6,002.99	6,604.53	6,583.70	6,576.15	6,010.20	6,690.13	7,575.42	8,381.93	8,648.16
Total Assets	8,397.00	8,840.06	9,993.15	9,984.16	9,979.04	9,648.27	10,554.75	11,402.42	12,195.37	12,567.02

Cash Flow

In Million

	Q1 - 2023	Q2 - 2023	Q3 - 2023	Q4 - 2023	Q1 - 2024	Q2 - 2024	Q3 - 2024	Q4 - 2024	Q1 - 2025	Q2 - 2025	Trend
Cash Flow From Operating Activities	658.16	724.68	394.46	-329.00	45.71	1,156.92	1,648.72	1,337.59	-54.42	338.83
Cash Flow From Investing Activities	35.80	-97.76	-67.35	-780.83	9.50	-233.89	-503.77	-511.94	-27.53	-49.41
Cash Flow From Financing Activities	-554.22	-475.22	106.61	863.24	-74.31	-1,078.00	-1,092.13	-958.86	5.36	-397.81
Net Increase/(Decrease) in Cash and Cash Equivalents	139.75	151.71	433.73	-246.59	-19.09	-154.96	52.82	-133.20	-76.58	-108.38
Cash and Cash Equivalents at the Beginning of the Year	27.48	27.48	27.48	1,658.11	1,411.53	1,411.53	1,411.53	1,411.53	1,278.33	1,278.33
Cash and Cash Equivalents at the End of the Year	167.24	179.19	461.21	1,411.53	1,392.44	1,256.57	1,464.35	1,278.33	1,201.75	1,169.96